2m 2m 2m 2m 2m 2m 2m
TRAVERE THERAPET (TVTX)
NASDAQ
$52.43-$0.16 (-0.29%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.0BMarket Cap
- 91.34%1-Year Change
- BiotechnologyIndustry
TRAVERE THERAPET (TVTX)
$52.43-$0.16 (-0.29%)
TVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $52.58 | ||
Change | +$0.28 (+0.54%) | ||
Open | $52.88 | ||
High | $54.83 | ||
Low | $52.50 | ||
Previous Close | $52.30 | ||
Volume | 2,164,173 | ||
30-Day Average Volume | 1,929,014 | ||
1-Week Change | -1.30% | ||
1-Month Change | -16.35% | ||
1-Year Change | 91.34% | ||
3-Year Change | 627.25% | ||
5-Year Change | 108.40% | ||
Fundamentals | |||
Shares Outstanding | 94.3M | ||
Total Assets | $799.4M | ||
Market Cap | $5.0B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | $161.4M | ||
Net Income | -$34.8M | ||
Free Cash Flow | $58.1M | ||
EBIT | -$33.0M | ||
EBITDA | -$28.8M | ||
Net Working Capital | $463.1M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -189 | ||
Enterprise Value/Revenue | 34 | ||
P/B | 202 | ||
P/E | -142 | ||
PEG | -19 | ||
Price/Free Cash Flow | 85 | ||
Price/Operating Cash Flow | 85 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue